XML 38 R21.htm IDEA: XBRL DOCUMENT v3.25.0.1
Accrued Expenses and Other Current Liabilities
 12 Months Ended
Dec. 31, 2024
Payables and Accruals [Abstract]  
Accrued Expenses and Other Current Liabilities Accrued Expenses and Other Current Liabilities
The components of accrued expenses and other current liabilities were as follows:
As of December 31,
(in millions)20242023
Accrued rebates
$148.3 $144.0 
Employee compensation and related costs142.8 122.0 
Professional and consulting services51.6 34.1 
Liability associated with secured borrowings
12.2 — 
Other68.9 73.6 
Accrued expenses and other current liabilities$423.8 $373.7 
Product Warranty Costs
Reconciliations of the changes in the Company’s product warranty liability were as follows:  
Years Ended December 31,
(in millions)202420232022
Product warranty liability at beginning of year$10.3 $62.1 $6.8 
Warranty expense24.1 18.6 87.0 
Change in estimate(0.4)(11.5)(14.0)
Warranty fulfillment(20.1)(58.9)(17.7)
Product warranty liability at end of year$13.9 $10.3 $62.1 
In 2022, the Company issued two voluntary medical device correction notices (“MDCs”), one for its Omnipod DASH PDM relating to its battery and the other for its Omnipod 5 Controller relating to its charging port and cable. The Company initially accrued an estimated liability of $68.9 million related to these MDCs, which was subsequently revised by $11.0 million due to significantly fewer customers requesting a replacement Omnipod DASH PDM prior the Company’s updated PDM being available, resulting in a net charge of $57.9 million for the year ended December 31, 2022. During the year ended December 31, 2023, the Company further revised the estimated liability for these MDCs by 11.5 million. This change in estimate primarily resulted from lower shipping costs for replacement DASH PDMs and lower expected distribution costs for Omnipod 5 Controllers. The liability related to the MDCs included in product warranty liability at December 31, 2023 was insignificant and no amount was remaining as of December 31, 2024.